Chapter 10 Mmps and Adams in Inflammatory Bowel Disease

Total Page:16

File Type:pdf, Size:1020Kb

Chapter 10 Mmps and Adams in Inflammatory Bowel Disease Chapter 10 MMPs and ADAMs in Inflammatory Bowel Disease Alicja Wiercinska-Drapalo, Jerzy Jaroszewicz, Anna Parfieniuk, Anna Moniuszko Department of Infectious Diseases, Medical University of Bialystok, Zurawia 14 Str., 15-540 Bialystok, Poland. 1. INTRODUCTION Idiopathic inflammatory bowel disease (IBD) is classified into two distinct disorders: ulcerative colitis (UC) and Crohn’s diseases (CD). IBD are chronic inflammatory bowel diseases characterized by repeated episodes of intestinal inflammation and damage following by relapses and intestine wound healing. Although classified together, UC and CD show a different localization and to some extent different pathogenesis. Ulcerative colitis affects colon and the intestine lesions are superficial while Crohn’s disease may involve any part of gastrointestinal tract and is characterized by transmural granulomatous infiltrations. The exact pathogenesis of UC and CD is still mysterious. A number of studies suggested that CD is T-cell mediated disorder with excessive Th-1 cell activity associated with pro-inflammatory cytokine overproduction. Less information on pathogenesis of UC is available. Many authors believe that in contrast to CD the predominant immune response type is Th2, however this hypothesis is not fully documented, for example IL-4, classical Th2-type cytokine seems not to increase in UC. The common feature of CD and UC is extracellular matrix (ECM) remodeling associated with ongoing inflammatory responses and intestinal lesions healing. The regulation of ECM turnover is a dynamic process essential for embryonic development, morphogenesis, reproduction, and tissue resorption and remodeling. The major regulators of collagen synthesis and degradation 235 U. Lendeckel and Nigel M. Hooper (eds.), Proteases in Gastrointestinal Tissue, 235-254. © 2006 Springer. Printed in the Netherlands 236 A. WIERCINSKA-DRAPALO, J. JAROSZEWICZ, ET AL. Chapter 10 are zinc-dependant enodpeptidases - matrix metalloproteinases (MMPs) and their inhibitors (tissue inhibitors of metalloproteinases - TIMPs). 2. MATRIX METALLOPROTEINASES 2.1 Expression, regulation and functions in the gut The variety of cells in the intestine are able to produce MMPs, among them fibroblasts (MMP-1, 2, 3, 14), macrophages (MMP-1, 3, 9, 12), epithelial cells (MMP-7, 8, 10), neutrophils (MMP-8) and eosinophils (MMP-9). It is believed that the major source of MMP-1 and MMP-3 are macrophages and T-cells-induced MMP production by those cells links mucosal inflammation and tissue destruction in chronic gut diseases (Goetzl et al 1996). However in-situ hybridization studies indicate that α-actin positive cells such as myofibroblasts are a main source of MMP mRNAs in the inflamed gut, which is not confirmed in immunochemistry (Pender et al 1998). According to hypothesis presented by von Lampe et al (2000) MMP produced by α-actin positive cells are not stored within these cells and are secreted and bound to ECM. In contrast with majority of other cells macrophages are able to store pro-MMP. In physiological condition MMPs are present at low levels and their expression and activation is regulated at the level of gene expression, their precursors activation, interaction with ECM components as well as inhibition by TIPMs (Pender et al 2004). The MMP expression “inductors” include (Nagase et al 1999) growth factors, cytokines (including TNF-alpha, IL-1β), chemical agents (among them phorbol esters) and oncogenes. On the contrary increased MMPs gene expression may be downregulated by suppressive factors including TGF-beta1, retinoids and glucocrticoids. Recently cell-to- cell and cell-to-ECM interactions were underlined as a important regulators of MMPs gene expression. For example expression of MT1-MMP by fibroblasts in cell-culture is mediated by α2β1 integrin (Seltzer et al 1994). Most of MMPs are secreted from the cell in inactive forms and anchored to the cell surface thus their activity is restrained to cell membrane or extracellular matrix. Secreted MMPs are activated in-vivo by tissue or plasma proteinases or bacterial proteinases, mainly on the cell surface. In 1994 Sato et al. (1994) cloned the first membrane-type MMP (MT1-MMP named MMP-14) and they demonstrated it to be an activator of pro-MMP2 (Sato et al 1994). The subsequent studies suggested that this process requires both active MT1-MMP and TIMP-2 bound MT1-MMP. 10. MMPs and ADAMs in Inflammatory Bowel Disease 237 Tissue activity of MMPs is controlled by their endogenous inhibitors (TIMPs) by forming 1:1 complexes with zinc in MMPs. In some disorders the production of MMP exceeds the inhibitory potential of TIMP which results in imbalance between ECM synthesis and breakdown. This process was proposed as a potential etiology of fistulae formation in Crhon’s disease (Kirkegaard et al 2004). The most extensively studied function of metalloproteinases, since the first MMP discovery in 1962 (Gross and Lapiere 1962) is degradation of all classes of ECM including collagens, non-collagenous glycoproteins and proteoglycans. In-vitro studies showed considerable overlap in MMP substrates (especially fibronectin, laminins, elastin, type IV collagen), (Sternlicht et al 2001). Substrates selectivity in-vivo is regulated by enzyme affinity and compartmentalization. Since MMPs are anchored on the cell membrane, bound to integrins, CD44 or surface proteoglycans they maintain high concentration locally and are able to target specific substrates in the pericellular space. In spite of the most widely discussed role of MMPs/TIMPs in ECM turnover, recent findings suggested their function in the inflammation and immunity, as a pro-inflammatory cytokines, chemokines and other immune and inflammation regulators (Parks et al 2004; McQuibban et al 2000 and 2001). Increased or misregulated levels of MMPs as well as TIMPs are observed in the majority immune-related or chronic inflammatory disorders including IBD. However the exact role of MMP family members, which comprises of more then 24 related but distinct proteins, in inflammatory conditions was not yet entirely revealed. Targeting of immune system by MMPs could be a result of chemokine as well as cytokine activity modulation and gradient formation (McQuibban et al 2002). It was shown that selected MMPs are able to convert initial forms of chemotactic factors into antagonistic molecules. For example CC-chemokine ligand 7 (CCL7) is a substrate for MMP-2, which after cleavage looses its chemotactic abilities and functions as chemokine antagonist. Similarly MMP- 1, 3 and 14 are capable of cleaving CCL2 which is also mechanism of angiogenesis regulation. (Galvez et al 2005). This MMP functions illustrates a possible anti-inflammatory activity of MMPs. Moreover several authors shown MMPs are able to directly or indirectly activate various cytokines engaged in inflammatory and wound healing processes. In in-vitro models it was suggested that MMP-3, 9 as well as 14 are able to activate TGF-β1. Since TGF-β1 is a cytokine of a known anti-inflammatory and immunou- pressive activity this could be another mechanism of MMP-mediated immune restrain. On the other hand several MMPs are engaged in pro-inflammatory cytokine activation. Despite the major activator of TNF-α is ADAM17, a number of MMPs (MMP-1, 2, 3, 9 and 17) are capable of processing pro- TNF into active form in-vitro (Mohan et al 2002, English et al 2000). 238 A. WIERCINSKA-DRAPALO, J. JAROSZEWICZ, ET AL. Chapter 10 Additionally MMP-7 and MMP-12 activate pro-TNF on macrophages. Schonbeck et al (1997) showed that at least three of MMP family members, namely MMP-2, 3, 9 can cleave and activated IL-β precursor. Interestingly after IL-1β activation MMP3 is able to degrade this cytokine into inactive form. In conclusions the regulation of immune and inflammation by MMPs is complex, probably bimodal and unrevealed even to the extent whether they act as a pro-inflammatory or anti-inflammatory factors. 2.2 Matrix metalloproteinases in IBD The hallmark of an IBD is tissue degradation and lesion development resulting from uncontrolled and chronic inflammatory responses. Among the modulators of an IBD activity the role cytokines, growth factors, chemokines, free radicals and recently metalloproteinases and their endogenous inhibitors – TIMPs is underlined. A number of up to date studies pointed to MMPs as the most important proteolytic enzymes engaged in extracellular matrix degradation in inflammatory bowel diseases. Although many authors showed overexpression of majority MMPs in IBD the MMP-1 (collagenase-1) and MMP-3 (stromelysin-1) are believed to be predominant in the IBD pathogenesis. von Lampe et al (2000) studied the expression of various MMPs (MMP-1, MMP-2, MMP-3, MMP-14) as well as TIMPs (TIMP-1 and TIMP-2) in IBD (UC and CD) patients as well as healthy controls at the protein and mRNA levels. They found the low expression of MMP-1 and MMP-3 in normal colonic mucosa. However in inflamed colon samples from IBD patients authors observed that mRNA expression of all studied MMPs was significantly increased in inflamed compared with non-inflamed colonic mucosa. Median expression of MMP-1 increased 20-fold in CD and 42-fold in UC subjects with analogous 15-fold and 43-fold (respectively) increase of MMP-3 expression. The increase in the expression of MMP-2 and MMP-14 mRNA was less pronounced. Analogous data indicating the increase in MMP- 1 and MMP-2 expression were obtained by Stallmach et al. (2000). Another major finding arising from the study of von Lampe et al (2000) was a strong, positive correlation between the histological degree of acute inflammation and MMP-1, MMP-2 and MMP-3 mRNA expression. The strongest correlation was noted between procollagen type III and MMP-2 mRNA expression. The most prominent expression of MMPs was noted in severely inflamed tissues characterized by ulcerations. In another study Heuschkel et al (2000) found the similar relationship between MMP-1 expression and loss of mucosal integrity in children with IBD, with MMP-1 normalization after introduction of eneteral nutrition.
Recommended publications
  • An Adverse Role for Matrix Metalloproteinase 12 After Spinal Cord Injury in Mice
    The Journal of Neuroscience, November 5, 2003 • 23(31):10107–10115 • 10107 Development/Plasticity/Repair An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice Jennifer E. A. Wells,1 Tiffany K. Rice,1 Robert K. Nuttall,3 Dylan R. Edwards,3 Hakima Zekki,4 Serge Rivest,4 V. Wee Yong1,2 Departments of 1Clinical Neurosciences and 2Oncology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada, 3School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, United Kingdom, and 4Laboratory of Molecular Endocrinology and Department of Anatomy and Physiology, Laval University, Quebec, Quebec G1V 4G2, Canada We investigated the role of matrix metalloproteinases (MMPs) in acute spinal cord injury (SCI). Transcripts encoding 22 of the 23 known mammalian MMPs were measured in the mouse spinal cord at various time points after injury. Although there were significant changes in the expression levels of multiple MMPs, MMP-12 was increased 189-fold over normal levels, the highest of all MMPs examined. To evaluate the role of MMP-12 in SCI, spinal cord compression was performed in wild-type (WT) and MMP-12 null mice. Behavioral analyses were conducted for 4 weeks using the Basso–Beattie–Bresnahan (BBB) locomotor rating scale as well as the inclined plane test. The results show that MMP-12 null mice exhibited significantly improved functional recovery compared with WT controls. Twenty-eight days after injury, the BBB score in the MMP-12 group was 7, representing extensive movement of all three hindlimb joints, compared with 4 in the WT group, representing only slight movement of these joints.
    [Show full text]
  • (MMP10) Moderates Inflammation by Controlling Macrophage Activation
    Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation This information is current as Ryan S. McMahan, Timothy P. Birkland, Kate S. Smigiel, of September 26, 2021. Tyler C. Vandivort, Maryam G. Rohani, Anne M. Manicone, John K. McGuire, Sina A. Gharib and William C. Parks J Immunol 2016; 197:899-909; Prepublished online 17 June 2016; doi: 10.4049/jimmunol.1600502 Downloaded from http://www.jimmunol.org/content/197/3/899 Supplementary http://www.jimmunol.org/content/suppl/2016/06/16/jimmunol.160050 Material 2.DCSupplemental http://www.jimmunol.org/ References This article cites 72 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/197/3/899.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation Ryan S.
    [Show full text]
  • Peptides and Peptidomimetics As Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
    materials Review Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation Patrycja Ledwo ´n 1,2 , Anna Maria Papini 3 , Paolo Rovero 2,* and Rafal Latajka 1,* 1 Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland; [email protected] 2 Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health-Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, 50019 Sesto Fiorentino, Firenze, Italy 3 Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry “Ugo Schiff”, University of Florence, 50019 Sesto Fiorentino, Firenze, Italy; annamaria.papini@unifi.it * Correspondence: paolo.rovero@unifi.it (P.R.); [email protected] (R.L.) Abstract: Collagen fibres degradation is a complex process involving a variety of enzymes. Fibrillar collagens, namely type I, II, and III, are the most widely spread collagens in human body, e.g., they are responsible for tissue fibrillar structure and skin elasticity. Nevertheless, the hyperactivity of fibrotic process and collagen accumulation results with joints, bone, heart, lungs, kidneys or liver fibroses. Per contra, dysfunctional collagen turnover and its increased degradation leads to wound healing disruption, skin photoaging, and loss of firmness and elasticity. In this review we described the main enzymes participating in collagen degradation pathway, paying particular attention to enzymes degrading fibrillar collagen. Therefore, collagenases (MMP-1, -8, and -13), elastases, and cathepsins, together with their peptide and peptidomimetic inhibitors, are reviewed. This information, related Citation: Ledwo´n,P.; Papini, A.M.; to the design and synthesis of new inhibitors based on peptide structure, can be relevant for future Rovero, P.; Latajka, R.
    [Show full text]
  • Parallel Expression of Macrophage Metalloelastase (MMP-12) in Duodenal and Skin Lesions of Gut: First Published As 10.1136/Gut.48.4.496 on 1 April 2001
    496 Gut 2001;48:496–502 Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of Gut: first published as 10.1136/gut.48.4.496 on 1 April 2001. Downloaded from patients with dermatitis herpetiformis M T Salmela, SLFPender, T Reunala, T MacDonald, U Saarialho-Kere Abstract intraepithelial lymphocytes.2 The rash and Background—Dermatitis herpetiformis enteropathy improve on a gluten free diet, (DH) is a specific dermatological manifes- implying that DH is a specific skin manifesta- tation of coeliac disease and 80% of DH tion of mainly subclinical coeliac disease patients have gluten sensitive enteropathy (CD).23 manifested by crypt hyperplasia and vil- Matrix metalloproteinases (MMPs) are a lous atrophy. Matrix degradation mediated family of extracellular matrix (ECM) degrad- by collagenase 1 (MMP-1) and stromelysin ing enzymes that are collectively capable of 1 (MMP-3) has previously been implicated degrading essentially all ECM components in the pathobiology of coeliac intestine and and that can further be subdivided into cutaneous DH blisters. collagenases (MMP-1, -8, and -13), gelatinases Aims—To study expression of stromelysin (MMP-2 and -9), stromelysins (MMP-3, -7, 2, metalloelastase, collagenase 3, and mat- -10, and –12), membrane-type MMPs, and rilysin in the intestine and skin of DH other MMPs.45 The extracellular activity of patients. MMPs is regulated by TIMPs 1–4.6 We have Methods—In situ hybridisation using 35S previously reported that expression of MMP-1 labelled cRNA probes was performed on and -3 is enhanced in basal keratinocytes 7 duodenal biopsies of 15 DH patients, three surrounding neutrophil abscesses in DH skin.
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • Matrix Metalloproteinases As Potential Biomarkers and Therapeutic Targets in Liver Diseases
    cells Review Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases Eline Geervliet and Ruchi Bansal * Translational Liver Research, Department of Medical Cell BioPhysics, Technical Medical Centre, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands; [email protected] * Correspondence: [email protected]; Tel.: +31-53-489-3115 Received: 6 April 2020; Accepted: 13 May 2020; Published: 13 May 2020 Abstract: Chronic liver diseases, characterized by an excessive accumulation of extracellular matrix (ECM) resulting in scar tissue formation, are a growing health problem causing increasing morbidity and mortality worldwide. Currently, therapeutic options for tissue fibrosis are severely limited, and organ transplantation is the only treatment for the end-stage liver diseases. During liver damage, injured hepatocytes release proinflammatory factors resulting in the recruitment and activation of immune cells that activate quiescent hepatic stellate cells (HSCs). Upon activation, HSCs transdifferentiate into highly proliferative, migratory, contractile and ECM-producing myofibroblasts. The disrupted balance between ECM deposition and degradation leads to the formation of scar tissue referred to as fibrosis. This balance can be restored either by reducing ECM deposition (by inhibition of HSCs activation and proliferation) or enhancing ECM degradation (by increased expression of matrix metalloproteinases (MMPs)). MMPs play an important role in ECM remodeling and represent an interesting target for therapeutic drug discovery. In this review, we present the current knowledge about ECM remodeling and role of the different MMPs in liver diseases. MMP expression patterns in different stages of liver diseases have also been reviewed to determine their role as biomarkers.
    [Show full text]
  • Methods for Detection of Matrix Metalloproteinases As Biomarkers in Cardiovascular Disease Viorica Lopez-Avila
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of San Francisco The University of San Francisco USF Scholarship: a digital repository @ Gleeson Library | Geschke Center Biology Faculty Publications Biology 2008 Methods for Detection of Matrix Metalloproteinases as Biomarkers in Cardiovascular Disease Viorica Lopez-Avila Juliet Spencer University of San Francisco, [email protected] Follow this and additional works at: http://repository.usfca.edu/biol_fac Part of the Biology Commons, and the Cardiovascular Diseases Commons Recommended Citation Lopez-Avila, V and Spencer, JV. Methods for Detection of Matrix Metalloproteinases as Biomarkers in Cardiovascular Disease. Clinical Medicine Insights: Cardiology 2008:2 75-87. This Article is brought to you for free and open access by the Biology at USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in Biology Faculty Publications by an authorized administrator of USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. For more information, please contact [email protected]. REVIEW Methods for Detection of Matrix Metalloproteinases as Biomarkers in Cardiovascular Disease Viorica Lopez-Avila1 and Juliet V. Spencer2 1Agilent Technologies, Santa Clara, CA 95051, U.S.A. 2University of San Francisco, San Francisco, CA 94403, U.S.A. Abstract: Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteolytic enzymes that degrade extracel- lular matrix (ECM) components like collagen, fi bronectin, and laminin. While this activity is important for normal develop- ment, morphogenesis, and wound healing, deregulation of MMP activity has been implicated in a number of cardiovascular diseases, including congenital heart defects, atherosclerosis, myocardial infarction, and congestive heart failure.
    [Show full text]
  • Increased Matrix Metalloproteinase Activation in Esophageal Squamous
    Mukherjee et al. Journal of Translational Medicine 2010, 8:91 http://www.translational-medicine.com/content/8/1/91 RESEARCH Open Access Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma Sumana Mukherjee1, Mark J Roth2, Sanford M Dawsey2, Wusheng Yan1, Jaime Rodriguez-Canales1, Heidi S Erickson1, Nan Hu3, Alisa M Goldstein3, Philip R Taylor3, Annely M Richardson1, Michael A Tangrea1, Rodrigo F Chuaqui1, Michael R Emmert-Buck1* Abstract Background: Esophageal squamous cell carcinomas (ESCC) are usually asymptomatic and go undetected until they are incurable. Cytological screening is one strategy to detect ESCC at an early stage and has shown promise in previous studies, although improvement in sensitivity and specificity are needed. Proteases modulate cancer progression by facilitating tumor invasion and metastasis. In the current study, matrix metalloproteinases (MMPs) were studied in a search for new early detection markers for ESCC. Methods: Protein expression levels of MMPs were measured using zymography in 24 cases of paired normal esophagus and ESCC, and in the tumor-associated stroma and tumor epithelium in one sample after laser capture microdissection (LCM). MMP-3 and MMP-10 transcripts in both the epithelium and stroma in five cases were further analyzed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Results: Gelatin zymography showed bands corresponding in size to MMP-2, MMP-3, MMP-9, and MMP-10 enzymes in each of the 24 cancer cases. MMP levels tended to be higher in tumors than paired normal tissue; however, only the 45 kDa band that corresponds to the activated form of MMP-3 and MMP-10 was strongly expressed in all 24 tumors with little or no expression in the paired normal foci.
    [Show full text]
  • Enhanced Expression but Decreased Specific Activity of Matrix
    Journal of Clinical Medicine Article Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma Jacek Kudelski 1,*, Grzegorz Młynarczyk 1,2, Monika Gudowska-Sawczuk 3 , Barbara Mroczko 3,4 , Barbara Darewicz 1, Marta Bruczko-Goralewska 2, Krzysztof Sobolewski 2 and Lech Romanowicz 2 1 Department of Urology, Medical University of Bialystok, M. Skłodowskiej-Curie 24A St., 15-276 Białystok, Poland; [email protected] (G.M.); [email protected] (B.D.) 2 Department of Medical Biochemistry, Medical University of Bialystok, Adama Mickiewicza 2C St., 15-089 Białystok, Poland; [email protected] (M.B.-G.); [email protected] (K.S.); [email protected] (L.R.) 3 Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland; [email protected] (M.G.-S.); [email protected] (B.M.) 4 Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland * Correspondence: [email protected]; Tel./Fax: +48-85-746-86-24 Citation: Kudelski, J.; Młynarczyk, G.; Gudowska-Sawczuk, M.; Mroczko, B.; Abstract: Human urinary bladder cancer is a huge worldwide oncological problem causing many Darewicz, B.; Bruczko-Goralewska, M.; deaths every year. The degradation of extracellular matrix (ECM) induced by molecules such as Sobolewski, K.; Romanowicz, L. matrix metalloproteinases (MMPs) is one of the main factors influencing the process of metastasis Enhanced Expression but Decreased origination. The MMP expression is tied to tumor aggressiveness, stage, and patient prognosis.
    [Show full text]
  • (Pump-1), Secreted from Human Rectal Carcinoma Cell Line1
    [CANCER RESEARCH 50, 7758-7764, December 15. 1990] Purification and Characterization of Extracellular Matrix-degrading Metalloproteinase, Matrin (Pump-1), Secreted from Human Rectal Carcinoma Cell Line1 Kaoru Miyazaki,2 Yasuhisa Hattori, Fuminori Umenishi, Hidetaro Yasumitsu, and Makoto Umeda Division of Cell Biology, Kifiara Institute for Biological Research, Yokohama City University, 2-120-3 Nakamura-cho, Minami-ku, Yokohama, Kanagawa 232, Japan ABSTRACT nases (14-18), serine proteinases (19-22), thiol proteinases (23-25), and aspartic proteinases (26). Among the four classes A metalloproteinase with M, 29,000 was purified to homogeneity as a of proteinases, the metalloproteinases appear to play a major latent proenzyme from the conditioned medium of a human rectal carci role in matrix degradation. Recent studies have revealed a noma cell line CaR-1. This enzyme hydrolyzed casein more potently than family of secreted zinc metalloproteinases capable of degrading gelatin embedded in polyacrylamide gels in zymography assay. Calcium ECM proteins. These include interstitial collagenase (27-29), ion was essential for the activity. It exerted the maximum activity at pH 7-9. Its activity was stimulated by organomercurials, such as p-amino- type IV collagenases (or gelatinases) with M, 72,000 (16, 17) phenyl mercuric acetate and p-chloromercuric benzoic acid, and was and M, 92,000 (18), and stromelysin (transin) (30-34). The inhibited by 1,10-phenanthroline but was hardly affected by diisopropyl interstitial collagenase preferentially hydrolyzes the interstitial fluorophosphate and pepstatin. When the purified proenzyme was acti collagens of types I, II, and III, whereas type IV collagenases vated by the organomercurials, it effectively hydrolyzed fibronectin, do hydrolyze type IV basement membrane collagen but not type laminin, type IV basement membrane collagen, and several types of I collagen (16-18, 27).
    [Show full text]
  • Time-Resolved Analysis of the Matrix Metalloproteinase 10 Substrate Degradome
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome Schlage, Pascal ; Egli, Fabian E ; Nanni, Paolo ; Wang, Lauren W ; Kizhakkedathu, Jayachandran N ; Apte, Suneel S ; Auf dem Keller, Ulrich Abstract: Proteolysis is an irreversible post-translational modification that affects intra- and intercellu- lar communication by modulating the activity of bioactive mediators. Key to understanding protease function is the system-wide identification of cleavage events and their dynamics in physiological con- texts. Despite recent advances in mass spectrometry-based proteomics for high-throughput substrate screening, current approaches suffer from high false positive rates and only capture single states ofpro- tease activity. Here, we present a workflow based on multiplexed Terminal Amine Isotopic Labeling of Substrates (TAILS) for time-resolved substrate degradomics in complex proteomes. This approach significantly enhances confidence in substrate identification and categorizes cleavage events by specificity and structural accessibility of the cleavage site. We demonstrate concomitant quantification of cleavage site spanning peptides and neo-N and/or neo-C termini to estimate relative ratios of non-cleaved and cleaved forms of substrate proteins. By applying this strategy to dissect the matrix metalloproteinase 10 (MMP10) substrate degradome in fibroblast secretomes, we identified the extracellular matrix protein ADAMTS-like protein 1 (ADAMTSL1) as a direct MMP10 substrate and revealed MMP10-dependent ectodomain shedding of platelet-derived growth factor receptor alpha (PDGFR฀) as well as sequential processing of type I collagen. The data have been deposited to the ProteomeXchange Consortium with identifier PXD000503.
    [Show full text]
  • Matrix Metalloproteinases: How Much Can They Do?
    International Journal of Molecular Sciences Editorial Matrix Metalloproteinases: How Much Can They Do? Magnus S. Ågren 1,2,* and Ulrich auf dem Keller 3 1 Digestive Disease Center and Copenhagen Wound Healing Center, Bispebjerg Hospital, University of Copenhagen, 2400 Copenhagen, Denmark 2 Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2400 Copenhagen, Denmark 3 Department of Biotechnology and Biomedicine, Technical University of Denmark, 2800 Kongens Lyngby, Denmark; [email protected] * Correspondence: [email protected]; Tel.: +45-3863-5954 Received: 16 March 2020; Accepted: 9 April 2020; Published: 12 April 2020 Abstract: Zinc-dependent matrix metalloproteinases (MMPs) belong to metzincins that comprise not only 23 human MMPs but also other metalloproteinases, such as 21 human ADAMs (a disintegrin and metalloproteinase domain) and 19 secreted ADAMTSs (a disintegrin and metalloproteinase thrombospondin domain). The many setbacks from the clinical trials of broad-spectrum MMP inhibitors for cancer indications in the late 1990s emphasized the extreme complexity of the participation of these proteolytic enzymes in biology. This editorial mini-review summarizes the Special Issue, which includes four review articles and 10 original articles that highlight the versatile roles of MMPs, ADAMs, and ADAMTSs, in normal physiology as well as in neoplastic and destructive processes in tissue. In addition, we briefly discuss the unambiguous involvement of MMPs in wound healing. Keywords: extracellular matrix; inflammation; wound healing; cytokines; proteinases; interstitial collagens More than half a century ago, Gross and Lapière discovered a true collagenase, which was the first vertebrate matrix metalloproteinase (MMP) responsible for the resorption of the tail in the metamorphosing tadpole [1].
    [Show full text]